Human cortical neurogenesis is altered via glucocorticoid-mediated regulation of ZBTB16 expression.
Anthi C KrontiraCristiana CruceanuLeander DonyChristina KyrousiMarie-Helen LinkNils RekDorothee PöhlchenCatarina RaimundoSigne Penner-GoekeAlicia SchoweDarina CzamaraMarius Lahti-PulkkinenSara SammallahtiElina WolfordKati HeinonenSimone RoehVincenza SportelliBarbara WölfelMaik KödelSusann SauerMonika Rex-HaffnerKatri RäikkönenMarta LabeurSilvia CappelloElisabeth B BinderPublished in: Neuron (2024)
Glucocorticoids are important for proper organ maturation, and their levels are tightly regulated during development. Here, we use human cerebral organoids and mice to study the cell-type-specific effects of glucocorticoids on neurogenesis. We show that glucocorticoids increase a specific type of basal progenitors (co-expressing PAX6 and EOMES) that has been shown to contribute to cortical expansion in gyrified species. This effect is mediated via the transcription factor ZBTB16 and leads to increased production of neurons. A phenome-wide Mendelian randomization analysis of an enhancer variant that moderates glucocorticoid-induced ZBTB16 levels reveals causal relationships with higher educational attainment and altered brain structure. The relationship with postnatal cognition is also supported by data from a prospective pregnancy cohort study. This work provides a cellular and molecular pathway for the effects of glucocorticoids on human neurogenesis that relates to lasting postnatal phenotypes.
Keyphrases
- endothelial cells
- transcription factor
- induced pluripotent stem cells
- cerebral ischemia
- pluripotent stem cells
- preterm infants
- subarachnoid hemorrhage
- binding protein
- poor prognosis
- type diabetes
- metabolic syndrome
- pregnant women
- spinal cord injury
- neural stem cells
- adipose tissue
- electronic health record
- blood brain barrier
- insulin resistance
- dna binding
- oxidative stress